Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 16,32 € (-25,45 %). Medianen er 16,03 € (-26,77 %).

Køb	2
Behold	7
Sælg	2

Nyheder Til nyhedsfeedet

ProAssurance reaches 52-week high and makes progress on acquisition by The Doctors Company

Shares of ProAssurance Corp. hit a new 52-week high at $23.96, marking an increase of over 100% in the past year. The planned acquisition by The Doctors Company is moving forward after the US antitrust authority ended the waiting period early and shareholders approved the transaction by a large majority. The acquisition is expected to close in the first half of 2026, pending further regulatory approvals. » Mere på de.investing.com
ProAssurance reaches 52-week high as shareholders approve acquisition by The Doctors Company

ProAssurance shares hit a new 52-week high at $23.95, showing strong performance over the past year. Shareholders overwhelmingly approved the planned acquisition by The Doctors Company, with over 99% voting in favor. The deal is expected to close in the first half of 2026, pending regulatory approvals. After the acquisition, ProAssurance will become a wholly owned subsidiary of The Doctors Company and will be delisted from the New York Stock Exchange. » Mere på de.investing.com
ProAssurance hits 52-week high ahead of acquisition by The Doctors Company

Shares of ProAssurance reached a new 52-week high after shareholders overwhelmingly approved the planned acquisition by The Doctors Company. The deal is expected to close in the first half of 2026, pending further regulatory approvals, after which ProAssurance will be delisted. However, analysts have raised concerns about the valuation and the company's future earnings potential. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2023 har Proassurance Co. allerede udloddet 0,0918 € i udbytte. Den seneste udlodning fandt sted i april 2023.

Virksomhedstal

I det seneste kvartal havde Proassurance Co. en omsætning på 226,89 mio. € og et nettoresultat på 7,31 mio. €

(EUR)	marts 2026	YoY
Omsætning	226,89 mio.	-
Bruttofortjeneste	76,4 mio.	-
Nettoresultat	7,31 mio.	-
EBITDA	14,85 mio.	-

Fundamentale data

Nøgletal	Værdi
Markedsværdi	1,15 mia. €
Antal aktier	51,61 mio.
Højeste/laveste i 52 uger	22,28 € - 20,30 €
Udbytte	Nej
Beta	0,04
P/E (PE Ratio)	19,71
PEG (PEG Ratio)	0,37
K/I (PB Ratio)	0,96
P/S (PS Ratio)	1,20

Virksomhedsprofil

ProAssurance Corporation tilbyder gennem sine datterselskaber skade- og ansvarsforsikring samt genforsikringsprodukter i USA. Selskabet opererer gennem segmenterne Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance og Lloyd's Syndicate. Det tilbyder erhvervsansvarsforsikring for sundhedsudbydere og institutioner samt advokater; ansvarsforsikring for risici inden for medicinsk teknologi og biovidenskab; og arbejdsskadeforsikring, herunder garanteret omkostningspolicer, policyholder dividend-policer, retrospektivt bedømte policer og selvrisikopolicer, samt alternative markedsløsninger, der omfatter programdesign, fronting, skadesbehandling, risikostyring, SPC-leje, formuesforvaltning og SPC-administrationstjenester for enkeltvirksomheder, agenturer, grupper og foreninger. Selskabet deltager også i Lloyd's of London Syndicate 1729, som tegner skade- og ansvarsforsikring samt genforsikring. Det markedsfører sine produkter gennem uafhængige agenturer og mæglere samt en intern salgsstyrke. Selskabet blev grundlagt i 1976 og har hovedkvarter i Birmingham, Alabama.

Navn	Proassurance Co.
CEO	Edward Lewis Rand Jr.
Hjemsted	Birmingham, al USA
Websted	proassurance.com
Sektor	Finans
Branche	Forsikring
Børsnotering	04.09.1991
Medarbejdere	972